Clinical Trial

Electroclinical Correlates in Essential Tremor

Study acronym: ECOLOVIM
Completed
View on ClinicalTrials.gov →
Summary
Essential tremor (ET) is a neurological disorder that affects nearly 0.9% of the world's population. High-frequency Deep Brain Stimulation (DBS) of the ventral-intermediate nuclei of the thalamus (VIM) has been proven as an effective second-line treatment for severe forms of ET. The arrival on the market of the PERCEPT™ (new stimulator/recorder, Medtronic, Minneapolis, USA) now allows, in addition to the stimulation delivery, the recording of intracerebral activity at a distance from surgery, in a non-invasive way and in ecological condition at home. Investigators aim at recording the variations of thalamic Local Field Potentials (LFP) oscillations, in ecological condition, during rest and movement, with and without deep brain stimulation, once a week, between M3 and M6 post surgery.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-08
notable Primary completion moved earlier: 2026-05-03 -> 2025-07-16 2026-08-08
minor Completion moved earlier: 2026-05-03 -> 2025-11-26 2026-08-08
Trial Details
NCT Number NCT05671848
Lead Sponsor University Hospital, Bordeaux
Collaborators: MINDig
Conditions Essential Tremor
Enrollment 10 participants
Start Date 2023-05-03
Primary Completion 2025-07-16 (estimated)
Study Completion 2025-11-26 (estimated)
Updated on ClinicalTrials.gov 2026-08-07